Balance Sheet

v3.23.3

Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 3,226	$ 4,391
Short-term marketable securities		2,049
Prepaid expenses and other current assets	252	825
Deferred offering costs	41
Total assets	3,519	7,265
Current liabilities:
Accounts payable	350	534
Accrued expenses	1,255	568
Total current liabilities	1,605	1,102
Common warrant liability	1,908
Total liabilities	3,513	1,102
Commitments and contingencies
Stockholders’ equity:
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of September 30, 2023, and December 31, 2022, respectively; no shares issued and outstanding at September 30, 2023, and December 31, 2022
Common stock, $0.0001 par value, 250,000,000 shares authorized at September 30, 2023, and December 31, 2022; 10,693,080 and 9,097,701 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	1	1
Additional paid-in capital	38,183	37,318
Accumulated other comprehensive income		17
Accumulated deficit	(38,178)	(31,173)
Total stockholders’ equity	6	6,163
Total liabilities and stockholders’ equity	$ 3,519	$ 7,265

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source

Delivering Therapy Where it Matters

Quicklinks

Delivering Therapy Where it Matters

Quicklinks